Vangipuram Shankar

About

Dr. Vangipuram Shankar, MD, DNB, is a Senior Consultant and Clinical Lead in Radiation Oncology and Radiosurgery at Apollo Cancer Centre and Apollo Proton Cancer Centre, Chennai. With over two decades of experience in high-precision radiation therapy, he is widely recognized for his work in stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT) using photon and proton platforms, and functional radiosurgery.

A gold medalist in both MD (Radiotherapy) and DNB, Dr. Vangipuram completed advanced post-doctoral training at leading international centers, including Tata Memorial Hospital; an ICRETT–UICC fellowship at MD Anderson Cancer Center; UCSF; the University of Pittsburgh Medical Center (Gamma Knife); and specialized functional radiosurgery training at Aix–Marseille University, France.

His clinical expertise encompasses proton and photon radiosurgery for benign and malignant intracranial tumors, skull-base lesions, and arteriovenous malformations, as well as functional indications including trigeminal neuralgia, movement disorders, epilepsy, and obsessive–compulsive disorder. He also has extensive experience in complex extracranial SBRT involving the spine, lung, liver, pancreas, prostate, and head-and-neck cancers.

Dr. Vangipuram has held senior leadership roles across major cancer centers in India and has been actively involved in technology development, clinical workflow optimization, and regional training programs for advanced stereotactic platforms in collaboration with industry partners. An active investigator, he has contributed to multiple national and international clinical trials and has authored an extensive body of peer-reviewed publications focusing on radiosurgical innovation, imaging biomarkers, and functional neuro-oncology.

He is a long-standing member of AROI, ASTRO, ESTRO, and ISRS, and remains committed to advancing precision and proton-based radiosurgery through clinically grounded research and mentorship.

Employment

• Apollo Proton Cancer Centre Clinical Lead
  2019 - Present

Education

• Apollo Proton Cancer Centre MD,DNB

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Letter: Scoring System Assessing Risks of Growth in Sporadic Vestibular Schwannoma
  Neurosurgery 2026 DOI: 10.1227/neu.0000000000003828
  +Save
• Letter: Stereotactic Radiosurgery Dose Reduction for Melanoma Brain Metastases Patients on Immunotherapy or Target Therapy: A Single-Center Experience
  Neurosurgery 2025 DOI: 10.1227/neu.0000000000003795
  +Save
• Decoding dizziness: Non-Vestibular Influences Following Radiosurgical Management of Vestibular Schwannoma
  Neurochirurgie 2025 DOI: 10.1016/j.neuchi.2025.101731
  +Save
• Dr Google v Dr Real: Is it unethical to dismiss patients who self-diagnose?
  Indian Journal of Medical Ethics 2025 DOI: 10.20529/ijme.2025.079
  +Save
• Letter: Rethinking dose thresholds and biological complexity in SABR for colorectal lung metastases
  Radiotherapy and Oncology 2025 DOI: 10.1016/j.radonc.2025.111059
  +Save
• Post-radiosurgical management of vestibular schwannoma: contextualizing salvage microsurgical outcomes
  Journal of Clinical Neuroscience 2025 DOI: 10.1016/j.jocn.2025.111512
  +Save
• Attachment ≠ Origin: A Critical Appraisal of the Olfactory Schwannoma Literature
  Neurochirurgie 2025 DOI: 10.1016/j.neuchi.2025.101706
  +Save
• Reappraising OPTIMAL-HN: Pragmatic progress or premature pivot in RIM pain management?
  Radiotherapy and Oncology 2025 DOI: 10.1016/j.radonc.2025.111005
  +Save
• Letter to the Editor Regarding “Surgical Strategies in Basal Ganglia Gliomas: A Systematic Review of Resection Extent, Mortality, and Neurological Recovery”
  World Neurosurgery 2025 DOI: 10.1016/j.wneu.2025.124212
  +Save
• Letter to the Editor Regarding “Incidence and Risk Factors of Delayed Facial Paralysis After Vestibular Schwannoma Resection: A Systematic Review and Meta-Analysis”
  World Neurosurgery 2025 DOI: 10.1016/j.wneu.2025.124117
  +Save